Zai Lab Limited American Depositary Shares (ZLAB)

Price$23.50

Favorite Metrics

Price vs S&P 500 (26W)-36.88%

Price vs S&P 500 (4W)19.16%

Market Capitalization$19.73B

All Metrics

Book Value / Share (Quarterly)$0.65

P/TBV (Annual)3.10x

Revenue Growth (3Y)28.86%

Cash Flow / Share (Quarterly)$-0.15

Price vs S&P 500 (YTD)31.26%

Gross Margin (TTM)61.15%

Net Profit Margin (TTM)-38.15%

EPS (TTM)$-0.16

10-Day Avg Trading Volume16.30M

EPS Excl Extra (TTM)$-0.16

Revenue Growth (5Y)56.51%

EPS (Annual)$-0.16

ROI (Annual)-19.08%

Gross Margin (Annual)61.15%

Net Profit Margin (5Y Avg)-184.48%

Cash / Share (Quarterly)$0.62

Revenue Growth QoQ (YoY)16.99%

ROA (Last FY)-14.97%

Revenue Growth TTM (YoY)15.33%

EBITD / Share (TTM)$-0.19

ROE (5Y Avg)-38.12%

Operating Margin (TTM)-49.86%

Cash Flow / Share (Annual)$-0.15

P/B Ratio3.52x

P/B Ratio (Quarterly)2.75x

Net Income / Employee (Annual)$-0

EV / Revenue (TTM)4.45x

Net Interest Coverage (TTM)-9.59x

ROA (TTM)-15.04%

EPS Incl Extra (Annual)$-0.16

Current Ratio (Annual)2.45x

Quick Ratio (Quarterly)2.18x

3-Month Avg Trading Volume10.39M

52-Week Price Return-17.46%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.58

P/S Ratio (Annual)5.48x

Asset Turnover (Annual)0.39x

52-Week High$35.50

Operating Margin (5Y Avg)-186.24%

EPS Excl Extra (Annual)$-0.16

CapEx CAGR (5Y)4.70%

Tangible BV CAGR (5Y)-11.31%

26-Week Price Return-32.89%

Quick Ratio (Annual)2.18x

13-Week Price Return23.04%

Total Debt / Equity (Annual)0.29x

Current Ratio (Quarterly)2.45x

Enterprise Value$2,045.607

Revenue / Share Growth (5Y)46.10%

Asset Turnover (TTM)0.39x

Book Value / Share Growth (5Y)-13.45%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)3.12x

Pretax Margin (Annual)-38.78%

Cash / Share (Annual)$0.62

3-Month Return Std Dev52.41%

Gross Margin (5Y Avg)63.56%

Net Income / Employee (TTM)$-0

ROE (Last FY)-24.53%

Net Interest Coverage (Annual)-9.67x

EPS Basic Excl Extra (Annual)$-0.16

Receivables Turnover (TTM)4.81x

Total Debt / Equity (Quarterly)0.29x

EPS Incl Extra (TTM)$-0.16

Receivables Turnover (Annual)4.81x

ROI (TTM)-18.32%

P/S Ratio (TTM)5.48x

Pretax Margin (5Y Avg)-184.44%

Revenue / Share (Annual)$0.42

Tangible BV / Share (Annual)$0.58

Price vs S&P 500 (52W)-17.82%

Year-to-Date Return33.04%

5-Day Price Return11.75%

EPS Normalized (Annual)$-0.16

ROA (5Y Avg)-29.81%

Net Profit Margin (Annual)-38.15%

Month-to-Date Return32.55%

Cash Flow / Share (TTM)$-2.36

EBITD / Share (Annual)$-0.19

Operating Margin (Annual)-49.86%

ROI (5Y Avg)-36.20%

EPS Basic Excl Extra (TTM)$-0.16

P/TBV (Quarterly)3.10x

P/B Ratio (Annual)2.75x

Inventory Turnover (TTM)3.12x

Pretax Margin (TTM)-38.78%

Book Value / Share (Annual)$0.65

Price vs S&P 500 (13W)22.35%

Beta1.60x

Revenue / Share (TTM)$0.42

ROE (TTM)-22.81%

52-Week Low$12.31

Industry Peers — Pharmaceuticals(308)

Symbol	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
ZLABZai Lab Limited American Depositary Shares	5.48x	15.33%	61.15%	—	$23.50
LLYEli Lilly & Co.	13.08x	44.70%	83.04%	27.59%	$903.99
JNJJohnson & Johnson	5.94x	7.87%	67.95%	14.90%	$234.54
ABBVABBVIE INC.	6.04x	8.57%	71.62%	-2.88%	$208.99
MRKMerck & Co., Inc.	4.41x	1.31%	78.55%	21.23%	$115.46
AZNAstraZeneca PLC	5.28x	8.63%	81.31%	21.88%	$200.47
NVSNovartis AG	4.98x	8.91%	75.82%	15.26%	$149.73
NVONovo-Nordisk A/S	3.62x	6.43%	80.98%	20.66%	$40.93
ABTAbbott Laboratories	3.66x	6.59%	56.50%	8.20%	$95.47
PFEPfizer Inc.	2.47x	-1.64%	75.81%	-3.51%	$27.22
BMYBristol-Myers Squibb Co.	2.47x	-0.22%	72.63%	—	$58.96

About

Zai Lab is a biopharmaceutical company developing proprietary therapeutics in oncology, autoimmune disease, and infectious disease. The company's clinical pipeline is focused on targeted antibody-drug conjugates, including programs for solid tumors, small cell lung cancer, and neuroendocrine cancers. Key candidates include ZL-1218, ZL-1310, ZL-6301, and ZL-6201, addressing multiple tumor types with novel mechanisms of action.